Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
But I just have to......It’s going to blow!!!!
It’s flying now....so no ramping just staying the obvious
Thanks
Morning, can somebody inform me of total shares in issue....I can’t seem to find it anywhere.
Thanks
So for those of you who believe in market maker signals.....
There was a 1000 trade earlier today as well as 3rd last trade of the day : meaning “don’t let the stock run”
Then second last trade of the day a 500 : meaning gap in the stock - that could be up or down depending on trend.....
Not a believer myself ;)
I think it’s H1 of last year not the entire year, but still very good...
Sorry, my maths letting me down there....it’s $0.6 not $0.8.....
Michael 1ADR = 5 shares. So effectively $0.8 a share. Then take that to ÂŁ at what ever exchange rate we have at present....
If one look at the Nasdaq share value we should be sitting at around 85p...
3p is only the nominal value of the shares not the actual market value which at present is 60p....
Sam, the shares won’t be issued at 3p.....common surely you know that.
Always good to take a profit...and good luck with future investments
So it will be only trading on Nasdaq. To do that all you have to do is fill out a form with your broker so not a death sentence......
Also no specific date been given yet, other than Q2, 2020....but could potentially be delayed now with all going on...
Here you go:
Mon, 13th Jan 2020 07:00
RNS Number : 5180Z
Tiziana Life Sciences PLC
13 January 2020
Tiziana Life Science Plc (the "Company")
Proposed Cancellation from AIM
New York/London, 13 January 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that it has appointed advisers in relation to an intended redomicile of the Company to Bermuda which is anticipated to occur by Q2-2020, as a consequence of the redomicile the Company will not be seeking to re-admit its ordinary shares on AIM and will therefore seek shareholder consent for its shares to be cancelled from AIM when the redomicile occurs. A further announcement will be made in due course.
Furthermore, the Company intends to cancel its ADR program and have its Bermuda common shares listed on Nasdaq.
The Company is today attending the J.P. Morgan Healthcare Conference in San Francisco, a copy of the investor presentation that is being used by the Company is available for download from its website at www.tizianalifesciences.com.
Looking like we are going to finish above 40p for the first time......good momentum building. Hoping we don’t have any large sells afterwards and the background seller is gone....
Results been delayed, look at my post earlier today....
Found this on their website:
Tiziana Life Sciences plc (the “Company”) will be relying on the SEC Order to delay the filing of its Annual Report on Form 20-F for the year ended December 31, 2019 (the “Report”) due to the circumstances related to COVID-19. In particular, COVID-19 has caused severe disruptions in travel and transportation and limited access to the Company’s facilities resulting in limited support from its staff. This has, in turn, delayed the Company’s ability to complete its quarterly review and prepare the Report. Notwithstanding the foregoing, the Company expects to file the Report no later than June 14, 2020 (which is 45 days from the Report’s original filing deadline of April 30, 2020).......
So no annual report but hopefully an update on the covid-19 status